Assembly Biosciences, Inc. (NASDAQ:ASMB)

About the company

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

115

$16.00M

Total Revenue

115

Employees

$684.40M

Market Capitalization

-6.88

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-101M

Net Margin (in %)

Total net margin

$-96M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 12377.43 2872.00 6.22 118.67 3.63
Horizon Therapeutics Plc HZNP 11924.85 1376.00 5.08 18.80 43.06
Perrigo Co. Plc PRGO 7959.70 4837.00 1.36 54.30 3.02
Bausch Health Cos., Inc. BHC 6583.45 8597.00 9.19 -3.48 -21.96
Jazz Pharmaceuticals Plc JAZZ 6239.22 2188.00 2.16 22.80 12.81
United Therapeutics Corp. UTHR 5208.59 1443.00 1.81 10.05 36.59
MyoKardia, Inc. MYOK 4337.34 34.00 12.61 -13.99 -201.73
Axsome Therapeutics, Inc. AXSM 2873.15 None 19.50 -31.94 None
Pacira Biosciences, Inc. PCRX 2414.16 435.00 6.47 -5748.00 -0.02
SAGE Therapeutics, Inc. SAGE 2353.00 9.00 2.77 -3.63 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Prestige Consumer Healthcare, Inc. PBH 2006.85 963.00 1.69 14.15 14.77
Corcept Therapeutics, Inc. CORT 1984.94 335.00 4.56 18.70 31.64
Ironwood Pharmaceuticals, Inc. IRWD 1624.95 440.00 -23.00 19.17 19.14
Innoviva, Inc. INVA 1596.69 285.00 3.78 8.26 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1558.95 0.00 4.16 -15.26 -624.74
Revolution Medicines, Inc. RVMD 1534.59 48.00 3.98 -21.68 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1431.04 272.00 -42.59 -4.17 -127.53
Supernus Pharmaceuticals, Inc. SUPN 1346.76 402.00 2.14 11.55 28.90
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1321.20 5.00 3.61 -3.11 -241.62
Theravance Biopharma, Inc. TBPH 1255.14 88.00 -8.81 -5.09 -280.80
Revance Therapeutics, Inc. RVNC 1153.38 0.00 4.55 -6.18 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.17 327.00 2.49 19.55 15.90
BellRing Brands, Inc. BRBR 799.50 954.00 -0.43 6.07 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Eagle Pharmaceuticals, Inc. EGRX 711.20 192.00 3.82 282.22 1.29
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Aerie Pharmaceuticals, Inc. AERI 629.28 79.00 4.99 -3.11 -252.92
Collegium Pharmaceutical, Inc. COLL 590.24 299.00 4.22 -45.68 -4.21
Intersect ENT, Inc. XENT 576.80 102.00 5.45 -11.55 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 529.20 125.00 1.83 19.09 22.73
BioDelivery Sciences International, Inc. BDSI 414.92 130.00 5.93 -56.38 -5.01
ANI Pharmaceuticals, Inc. ANIP 354.72 203.00 1.81 -227.38 -0.67
Albireo Pharma, Inc. ALBO 309.92 11.00 3.15 -4.05 -730.55
MEI Pharma, Inc. MEIP 290.50 5.00 5.00 -7.45 -539.48
Mallinckrodt Plc MNK 260.40 3037.00 0.14 -0.22 -39.56
Agile Therapeutics, Inc. AGRX 149.86 None 2.44 -7.26 None
Cerecor, Inc. CERC 118.68 7.00 7.59 -5.27 -429.22
Marinus Pharmaceuticals, Inc. MRNS 115.92 0.00 5.26 -1.72 None
Ampio Pharmaceuticals, Inc. AMPE 92.95 1.00 65.00 -5.00 None
AcelRx Pharmaceuticals, Inc. ACRX 86.40 2.00 -1.59 -1.54 -644.25
Evoke Pharma, Inc. EVOK 85.44 397.00 29.67 -12.71 -0.76
Aclaris Therapeutics, Inc. ACRS 83.23 4.00 1.46 -0.60 None
Zynerba Pharmaceuticals, Inc. ZYNE 81.88 0.00 1.34 -2.28 -699.94
CTI BioPharma Corp. CTIC 81.42 3.00 3.63 -1.97 -111.83
Oramed Pharmaceuticals, Inc. ORMP 77.14 3.00 2.80 -7.12 -398.34
Adamas Pharmaceuticals, Inc. ADMS 75.04 57.00 -4.79 -0.81 -160.44
Cassava Sciences, Inc. SAVA 64.41 41.00 3.39 -14.13 76.71
Acasti Pharma, Inc. ACST 58.65 0.00 4.93 -2.30 -611.47
Natural Alternatives International, Inc. NAII 50.26 114.00 0.69 -13.30 -3.19
Cumberland Pharmaceuticals, Inc. CPIX 49.35 47.00 1.00 -10.97 -9.59
SCYNEXIS, Inc. SCYX 46.92 0.00 9.86 -1.21 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Lipocine, Inc. LPCN 38.70 0.00 9.21 -2.58 None
Neos Therapeutics, Inc. NEOS 31.75 65.00 -2.44 -1.81 -26.74
PLx Pharma, Inc. PLXP 25.74 0.00 -2.47 -2.72 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.64 3.00 2.57 -1.74 -264.21
Regulus Therapeutics, Inc. RGLS 16.38 0.00 1.44 -0.76 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 11.47 None 1.48 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.02 None 1.77 3.01 None
Sonoma Pharmaceuticals, Inc. SNOA 6.61 19.00 1.50 -3.32 -15.56
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.72 73.00 -0.13 -0.19 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 3.99 None 1.00 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection

6d ago, source: YAHOO!

Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting.

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13d ago, source: Business Insider

July 02, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and ...

BRIEF-Assembly Biosciences Announces FDA Fast Track Designation Granted To Abi-H2158

7d ago, source: Reuters

* ASSEMBLY BIOSCIENCES - ABI-H2158 IS BEING EVALUATED IN AN ONGOING GLOBAL PHASE 2 TRIAL Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles.

Assembly Biosciences Inc.

3d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

What You Need To Know About The Assembly Biosciences, Inc. (NASDAQ:ASMB) Analyst Downgrade Today

26d ago, source: Yahoo! News

The analysts covering Assembly Biosciences, Inc. (NASDAQ:ASMB) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. There ...

Hedge Funds Still Bullish On Assembly Biosciences Inc (ASMB)

23d ago, source: Insider Monkey

In this article, we analyze how these elite funds and prominent investors traded Assembly Biosciences Inc (NASDAQ:ASMB) based on those filings. Video: Watch our video about the top 5 most popular ...

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13d ago, source: wallstreet online

SOUTH SAN FRANCISCO, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.